MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    Combined Botulinum Toxin and Gpi DBS therapy in intractable cervical dystonia

    AM. Macerollo, BH. Hammersley, ME. Esposito, JS. Somerset, RE. Ellis, MB. Bonello, JP. Panicker, DD. Damodoran, JOF. Farah, PE. Eldridge, SA. Alusi (Naples, Italy)

    Objective: To test whether the reintroduction of Botulinum Toxin Injections (BTI) after Globus pallidus interna Deep Brain Stimulation (Gpi-DBS) for intractable cervical dystonia synergistically improves…
  • 2019 International Congress

    Trust the Patient’s Report, not the Doctor’s: Non-Motor Symptoms and Quality of Life in Cervical Dystonia

    I. Ndukwe, J. Dover, P. Lynch, C. O'Neill, S. O'Riordan, M. Hutchinson (Dublin, Ireland)

    Objective: To assess the prevalence of mood disorder and measure health-related quality of life (Hr-QoL) in relation to, pain, disability and disease severity in cervical…
  • 2019 International Congress

    Pregnancy and Delivery Complications in Women with Inherited Isolated Dystonia

    M. San Luciano, V. Shanker, S. Bressman, D. Raymond, R. Saunders-Pullman (San Francisco, CA, USA)

    Objective: To determine whether female mutation carriers of inherited dopa-responsive (DRD) and DYT/TOR1A genes had higher pregnancy and delivery complications than non-carriers Background: Women with…
  • 2019 International Congress

    PRRT2 mutations are associated with a wide intrafamilial ad interfamilial phenotypic variability

    M. Vizziello, R. Dilena, A. Giacobbe, E. Monfrini, G. Franco, A. Di Fonzo (Milano, Italy)

    Objective: To describe the different clinical syndromes associated with PRRT2 mutations in two different families Background: Mutations in the Proline-Rich Transmembrane Protein 2 (PRRT2) gene…
  • 2019 International Congress

    Guided Self-rehabilitation Contracts combined with simultaneous injections of abobotulinumtoxinA into upper and lower limbs in spastic hemiparesis: baseline data from the ENGAGE study

    J-M. Gracies, G. Francisco, R. Jech, S. Khatkova, C. Rios, P. Maisonobe (Créteil, France)

    Objective: To report baseline data from ENGAGE, an international phase 3b/4, prospective, single-arm, open-label study (NCT02969356) conducted in France, the Czech Republic, Russia and the USA.…
  • 2019 International Congress

    Algorithm of a differentiated approach to the management of patients with tic hyperkinesis

    S. Munasipova, Z. Zalyalova (Kazan, Russian Federation)

    Objective: Develop an algorithm for diagnosis and differentiated approach to the management of patients with tics Background: The prevalence of tics reaches 20%; often accompanied…
  • 2019 International Congress

    Is directional stimulation of the VIM superior to omnidirectional stimulation in patients with essential tremor?

    S. Fliegen, P. Nikolov, C. Hartmann, P. Slotty, J. Vesper, A. Schnitzler, S. Groiß (Düsseldorf, Germany)

    Objective: To determine whether directional stimulation of the VIM is superior to omnidirectional stimulation in essential tremor. Background: Deep brain stimulation (DBS) of the VIM…
  • 2019 International Congress

    Searching for the optimal functional target for deep brain stimulation in Essential Tremor

    D. Kübler, B. Al-Fatly, D. Kroneberg, S. Ewert, C. van Riesen, G-H. Schneider, A. Horn, A. Kühn (Berlin, Germany)

    Objective: To investigate tremor improvement but also side effects of deep brain stimulation (DBS) for essential tremor (ET) and their relationship to the volumes of…
  • 2019 International Congress

    Deep Brain Stimulation of VIM Thalamic Nucleus for Tremor Control

    J. Santos (Rio de Janeiro, Brazil)

    Objective: Compare safety, tolerability, efficiency and efficacy of DBS (VIM DBS) for tremor in Parkinson’s disease (PD) and Non Parkinsonian Patients over 25 years. Background:…
  • 2019 International Congress

    A case of donepezil-induced multifocal myoclonus

    C. Amlang, P. Kim, A. Padalia, B. Roy, S. Schaefer (New Haven, CT, USA)

    Objective: To describe the case of a patient who developed severe multifocal myoclonus due to donepezil. Background: Donepezil is a cholinesterase inhibitor frequently used to…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • …
  • 217
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
    • Effect of marijuana on Essential Tremor: A case report
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley